Malignant Uterine Neoplasm — Trials

Malignant Uterine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 824
Recruiting: 456
Ph III recruiting: 55
Growth YoY: −3.6%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (333)

clinicaltrialsPublishedShowing 51–52 of 52 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01779128	PET-CT vs. Integrated MR-PET Scanning of GYN Cancers	unknown	Early Phase 1	100	Massachusetts General HospitalOTHER	1	Jan 30, 2013	clinicaltrials
NCT00584207	Radiofrequency Ablation of Uterine Fibroids	terminated	Early Phase 1	15	University of California, DavisOTHER	1	Apr 23, 2009	clinicaltrials